Published on 8 Nov 2021 on Zacks via Yahoo Finance

Wall Street Analysts Think CryoLife (CRY) Could Surge 51%: Read This Before Placing a Bet

Shares of CryoLife (CRY) have gained 1.9% over the past four weeks to close the last trading session at $22.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $33.44 indicates a potential upside of 50.8%.

The mean estimate comprises four short-term price targets with a standard deviation of $4.48. While the lowest estimate of $29 indicates a 30.8% increase from the current price level, the most optimistic analyst expects the stock to surge 75.8% to reach $39. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.